IZERVAY FDA approval date

The FDA approved IZERVAY on 4 Aug 2023.

FDA approval date
4 Aug 2023

Drug identity has not yet been verified against registry records

Also recorded as AVACINCAPTAD PEGOL SODIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-08-04DayIZERVAYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217225", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["IZERVAY"], "active_ingredients": ["AVACINCAPTAD PEGOL SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230804", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026